Significance of TP53 mutation in treatment and prognosis in head and neck squamous cell carcinoma

Biomark Med. 2021 Jan;15(1):15-28. doi: 10.2217/bmm-2020-0400.

Abstract

Background:TP53 is ranked as the most common mutated gene in head and neck squamous cell carcinoma (HNSCC). Results: The status of TP53 mutation was investigated on International Cancer Genome Consortium and The Cancer Genome Atlas database and TP53-related differentially expressed genes were screened out from transcriptome data and mutation information. A TP53-related prognostic gene signature (TIMP4, ONECUT2, CGNL1, DMRTA2 and NKX2.3) was constructed based on Cox regression analysis and LASSO algorithm. Univariate and multivariate analyses were carried out to identify promising prognosticators for HNSCC. Conclusion: Our findings provide a well-rounded landscape of TP53 mutation in HNSCC and pave the groundwork for developing innovative and effective cancer treatment methods for HNSCC.

Keywords: TP53 mutation; The Cancer Genome Atlas; head and neck squamous cell carcinoma; prognosis signature.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mutation
  • Prognosis
  • Squamous Cell Carcinoma of Head and Neck*